Molecules / Fluvoxamine

Fluvoxamine API manufacturers

CAS 54739-18-3 ATC N06AB08 · SSRI antidepressants Updated 9 July 2026
13
manufacturers with an active filing 10 of them hold a US DMF or a CEP
$385.00
median export price per kg $275.00 to $450.00 · 8 exporters · 2025
46
shortage records on file across 3 countries
150
finished-dose makers across 37 regulators
Showing 13 of 13 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Cohance Lifesciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs and one valid CEP for fluvoxamine, filing since 2015. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
2 active
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
02

Apotex

Canada
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fluvoxamine, filing since 1999. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
23 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Medichem

Spain
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fluvoxamine, filing since 1999. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
7 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Lonza

Switzerland
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fluvoxamine, filing since 2011. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2026 · VAI
GMP recognised in
4 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Alivus Life Sciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for fluvoxamine, filing since 2025. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Ami Lifesciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fluvoxamine, filing since 2026. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Dasami Lab

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for fluvoxamine, filing since 2021. Its 2025 FDA inspection closed as VAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Veranova Lp

United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fluvoxamine, filing since 2007.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
10

Lake Chemicals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for fluvoxamine, filing since 2026. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
11

Registered with DAV (Vietnam) for fluvoxamine. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
12

SaVipharm J.S.C

Vietnam
Makes the APIFinished dose

Registered with DAV (Vietnam) for fluvoxamine. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
13

Wealphar Pharmaceutical Joint Stock

Vietnam
Makes the APIFinished dose

Registered with DAV (Vietnam) for fluvoxamine. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

10 more manufacturers hold filings for fluvoxamine

The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.

Jewim Pharmaceutical (Shandong)LonzaAlivus Life SciencesAmi LifesciencesDasami LabVeranova LpLake ChemicalsCông ty cổ phần SX - TM dược phẩm Đông NamSaVipharm J.S.CWealphar Pharmaceutical Joint Stock
Chat with Fred, your AI analyst

Contract manufacturers (1)

Olon Italy

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (19)

Ajanta Pharma India Teva Israel Viatris United States Hetero India Synthimed Labs India Torrent Pharmaceuticals India Abbott Laboratories United States Chartwell RX United States Eurofarma Laboratorios Brazil Gilead Sciences United States Ranbaxy Malaysia Sdn Bhd Malaysia Sandoz Switzerland Abbott Healthcare Products Netherlands Abbott Laboratorios Do Brasil Ltda Brazil Atlantic Pharma - Producoes Farmaceuticas Portugal Eg S P A Italy 'Công ty cổ phần dược phẩm ME DI SUN Vietnam Laboratorios Demac, Ltda Colombia Mash premiere Egypt

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators
Price band
Customs export unit values for 2025. These are export values rather than contract prices for regulated-market grade material, which are higher.

Who makes fluvoxamine?

Ask Fred which manufacturers are on record for fluvoxamine and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Also on this molecule

Price history 3 yrs Shortages 46 Finished dose 19 Contract mfrs 1

By country

India 5

Export price by year

Year Median Exporters
2025 $385.00 8
2024 $442.92 14
2023 $425.06 6

US dollars per kilogram, customs export unit values.